• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Model Number S0607
Device Problem Contamination (1120)
Patient Problem Bacterial Infection (1735)
Event Date 08/24/2021
Event Type  Injury  
Manufacturer Narrative
Analysis report was received from third party and will be further investigated.A review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.
 
Event Description
It was reported to gore that the patient underwent surgical treatment to create an access for hemodialysis with a gore-tex® stretch vascular graft ¿ standard-walled.It was stated that the vascular graft was implanted on (b)(6) 2021.It was reported that on (b)(6) 2021, after about 4 months, the vascular graft was explanted due to infection with staphylococcus aureus méti-r.A segment of the graft was sent for analysis.
 
Manufacturer Narrative
Explant investigation: the device was returned to geprovas for investigation.Submitted in formalin was a gore-tex® stretch vascular graft fragment.The scope and results of the investigation were summarized, and a report was submitted to w.L.Gore & associates.An explant scientist at w.L.Gore & associates reviewed the report.Explant scientist observations: the graft fragment was reported to measure 15 mm in length with both ends transected and the fragment longitudinally transected.Extremity a was bluntly cut while extremity b presented in a beveled fashion with monofilament blue suture in a continuous pattern along its edge, consistent with an anastomotic site.The ablumen was covered in thin layer of tan to yellow tissue and the blue alignment marks were faintly visible.An area of dark red/brown and yellow material was present near extremity b.The lumen at extremity a was devoid of tissue.Extremity b lumen was occluded by light tan tissue as confirmed by gore during on-site visit.Material disruptions (e.G., transections) were consistent with those caused by surgical instrumentation (e.G., scalpel, scissors) during a surgical procedure.The reported reason for removal was infection, source was not provided, and there was no accusation of infection being device related from the physician.Based on the explant scientist¿s review of the geprovas report and reason for removal, no additional analysis is requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14201693
MDR Text Key290051475
Report Number2017233-2022-02884
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132611317
UDI-Public00733132611317
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K903931
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberS0607
Device Catalogue NumberS0607
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/31/2022
Initial Date FDA Received04/26/2022
Supplement Dates Manufacturer Received06/14/2022
Supplement Dates FDA Received07/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/20/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient SexMale
-
-